Peculiarities of IgA-nephropathy clinical course, associated with excess body mass weight


Дәйексөз келтіру

Толық мәтін

Аннотация

Aim. Determination of peculiarities of IgA-nephropathy clinical course in overweight patients.
Methods. Retrospective study in 89 patients with IgA-nephropathy: 35 (21 male, 14 female) overweight (body mass index (BMI) 27,9±2,3 kg/m2) and 54 (30 male, 24 female) - with normal weight (BMI 21,8+2,2 kg/m2). Blood pressure, proteinuria, glomerular filtration rate (GFR), serum creatinine level, as well as ultrasound sighs of liver steatosis prevalence and serum AST, ALT and γ-GT activity were analyzed. Renal survival were calculated according to log-rank test.
Results. In overweight patients IgA-nephropathy is associated with higher blood pressure (mean BP 105,3±16,7 vs 98,7±13,7 mm Hg, p<0,05) and GFR (102±32 vs 81±27 ml/min/1,73m2, p<0,05), higher prevalence of ultrasound sighs of liver steatosis prevalence and higher serum AST, ALT and γ-GT activity levels.
Conclusion. Peculiarities of clinical course of IgA-nephropathy in overweight patients can be partly associated with deteriorated liver elimination of IgA due to nonalcoholic fatty liver disease.

Авторлар туралы

E Saginova

A Aksyutin

T Krasnova

V Fomin

N Mukhin

Әдебиет тізімі

  1. Мухин Н.А., Балкаров И.М., Максимов Н.А. Клинические проявления нарушений пуринового обмена в практике интерниста. Тер. арх. 1994; 1: 35-39
  2. Тареева И.Е. (ред.) Нефрология. Руководство для врачей. Москва. Медицина. 2000.
  3. Amore A., Roccatello D., Picciotto G, Emancipator S.N. Processing of IgA aggregates in a rat model of chronic liver disease. Clin. Immunol. Immunopathol. 1997; 84(2): 107-114
  4. Coppo R., Amore A., Roccatello D., Gianoglio B. Role of food antigens and alcohol in idiopathic nephritis with IgA deposits. Minerva Urol. Nefrol. 1991; 43(3): 171-174
  5. Lee E.Y., Chung C.H., Choi S.O. <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=10576158&query_hl=4&itool=pubmed_DocSum> Immunoglobulin A nephropathy in patients with non-insulin dependent diabetes mellitus. J Korean Med Sci. 1999; 14(5):582-585
  6. Orfila C., Lepert J.C., Modesto A. et al. <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=9678427&query_hl=13&itool=pubmed_docsum> IgA nephropathy complicating diabetic glomerulosclerosis. Nephron. 1998; 79(3): 279-287
  7. Chien K.L., Hsu H.C., Chao C.L. <http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&dopt=AbstractPlus&list_uids=16707022&query_hl=22&itool=pubmed_DocSum> et al. Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study. Cardiovasc. Diabetol. 2006; 5: 12
  8. Praga M., Hernandez E., Morales E. Clinical features and long-term outcome of obesity- associated focal segmental glomerulosclerosis. Nephrol. Dial. Transplant 2001; 15: 1790 - 1798
  9. Novak J., Julian B.A., Tomana M. et al Progress in molecular and genetic studies of IgA nephropathy. J Clin Immunol 2001; 21: 310-327
  10. Mestecky J., Tomana M., Crowley-Nowick P.A. et al. Defective galactosylation and clearance of IgA1 molecules is a possible etiopathogenic factor in IgA nephropathy. Contrib. Nephrol. 1993; 104:172-182
  11. Szцnyi L <http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Sz%C3%B6nyi%20L%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus>., Dobos M <http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22Dobos%20M%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus>., Vбsбrhelyi B <http://www.ncbi.nlm.nih.gov/sites/entrez?Db=pubmed&Cmd=Search&Term=%22V%C3%A1s%C3%A1rhelyi%20B%22%5BAuthor%5D&itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_DiscoveryPanel.Pubmed_RVAbstractPlus>. et al. Prevalence of alpha1-antitrypsin phenotypes in patients with IgA nephropathy. Clin. Nephrol. <javascript:AL_get(this,%20'jour',%20'Clin%20Nephrol.');> 2004; 62(6): 418-422
  12. Rifai A., Fadden K., Morrison S.L. et al. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulins (Ig) A1 and IgA2 isotypes. J. Exp. Med. 2000; 191: 2171-2182
  13. Myllymäki J., Syrjänen J., Helin H. et al. Vascular diseases and their risk factors in IgA nephropathy. Nephrol. Dial. Transplant. 2006; 21(7): 1876-1882
  14. Jiang <http://ndt.oxfordjournals.org/cgi/content/full/23/12/3921?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&andorexacttitle=and&titleabstract=IgA+nephropathy&andorexacttitleabs=and&fulltext=IgA+nephropathy&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&fdate=1/1/2005&resourcetype=HWCIT> L., Zhang <http://ndt.oxfordjournals.org/cgi/content/full/23/12/3921?maxtoshow=&HITS=10&hits=10&RESULTFORMAT=1&andorexacttitle=and&titleabstract=IgA+nephropathy&andorexacttitleabs=and&fulltext=IgA+nephropathy&andorexactfulltext=and&searchid=1&FIRSTINDEX=0&sortspec=relevance&fdate=1/1/2005&resourcetype=HWCIT> L.J., Lv L.-V. et al. Malignant hypertension in IgA nephropathy was not associated with background pathological phenotypes of glomerular lesions. Nephrol. Dial. Transplant. 2008; 23(12): 3921-3927
  15. Kurukulasuriya L.R., Stas S., Lastra G. et al. Hypertension in obesity. Endocrinol. Metab. Clin. North Am. 2008; 37(3): 647-662

Қосымша файлдар

Қосымша файлдар
Әрекет
1. JATS XML
Жүктеу

Осы сайт cookie-файлдарды пайдаланады

Біздің сайтты пайдалануды жалғастыра отырып, сіз сайттың дұрыс жұмыс істеуін қамтамасыз ететін cookie файлдарын өңдеуге келісім бересіз.< / br>< / br>cookie файлдары туралы< / a>